Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Development of Novel Therapeutic Agents for Breast Cancer through Targeting Nicotinic Acetylcholine Receptors.
Wu, Chih-Hsiung
(PI)
Ho, Yuan-Soon
(CoI)
Lee, Chia-Hwa
(CoI)
Division of General Surgery
Graduate Institute of Medical Sciences
School of Medical Laboratory Science and Biotechnology
TMU Research Center of Cancer Translational Medicine
Master Program in Applied Epidemiology
Ph.D. Program in Medical Biotechnology
Project
:
A - Government Institution
›
c - Ministry of Health and Welfare
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Nicotinic Receptor
100%
Trastuzumab
66%
Neoplasm
41%
Breast Tumor
33%
Cancer Staging
8%
Acute Toxicity
8%
Drug Resistance
8%
Malignant Neoplasm
8%
Tumor Growth
8%
Cancer Growth
8%
Cancer Antibody
8%
Anticancer Drug
8%
Biochemistry, Genetics and Molecular Biology
Nicotinic Acetylcholine Receptor
100%
Trastuzumab
100%
Complex Formation
25%
Cancer Cell
25%
Energy Transfer
12%
RNA
12%
Drug Resistance
12%
Anticancer
12%
Nicotinic Receptor
12%
Animal Model
12%
Tumor Progression
12%
Binding Affinity
12%
Antibody Library
12%
Immune Response
12%
Cancer Staging
12%
Cancer Stem Cell
12%